Have a feature idea you'd love to see implemented?
Let us know!
MGTX MeiraGTx Holdings plc
Price (delayed)
$5.92
Market cap
$462.67M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.21
Enterprise value
$424.37M
MeiraGTx is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in
Highlights
The revenue has soared by 108% YoY and by 71% QoQ
The quick ratio has soared by 58% YoY
The gross margin has plunged by 86% from the previous quarter and by 86% YoY
The company's gross profit has shrunk by 76% QoQ and by 71% YoY
Key stats
What are the main financial stats of MGTX
Market
Valuations
Earnings
Shares outstanding
78.15M
Market cap
$462.67M
Enterprise value
$424.37M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.01
Price to sales (P/S)
30.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
30.47
Revenue
$13.93M
Gross profit
$1.94M
Net income
-$88.18M
EBIT
-$74.87M
EBITDA
-$61.2M
Free cash flow
-$19.89M
Per share
Balance sheet
Liquidity
EPS
-$1.21
EPS diluted
-$1.21
Free cash flow per share
-$0.28
Book value per share
$1.48
Revenue per share
$0.19
TBVPS
$4.17
Total assets
$299.49M
Total liabilities
$203.75M
Debt
$86.74M
Equity
$95.74M
Working capital
$79.63M
Debt to equity
0.91
Current ratio
2.34
Quick ratio
2.16
Net debt/EBITDA
0.63
Margins
Efficiency
Dividend
EBITDA margin
-439.4%
Gross margin
14%
Net margin
-633%
Operating margin
-1,267%
Return on assets
-29.3%
Return on equity
-81%
Return on invested capital
-35.2%
Return on capital employed
-31.2%
Return on sales
-537.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MGTX stock price
How has the MeiraGTx Holdings stock price performed over time
Intraday
2.6%
1 week
-6.77%
1 month
-3.27%
1 year
-6.92%
YTD
-2.79%
QTD
-2.79%
Financial performance
How have MeiraGTx Holdings's revenue and profit performed over time
Revenue
$13.93M
Gross profit
$1.94M
Operating income
-$176.48M
Net income
-$88.18M
Gross margin
14%
Net margin
-633%
The revenue has soared by 108% YoY and by 71% QoQ
The gross margin has plunged by 86% from the previous quarter and by 86% YoY
The company's gross profit has shrunk by 76% QoQ and by 71% YoY
MeiraGTx Holdings's net margin has surged by 68% YoY and by 45% QoQ
Growth
What is MeiraGTx Holdings's growth rate over time
Valuation
What is MeiraGTx Holdings stock price valuation
P/E
N/A
P/B
4.01
P/S
30.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
30.47
MGTX's EPS has soared by 51% year-on-year and by 14% since the previous quarter
The stock's price to book (P/B) is 26% more than its 5-year quarterly average of 3.1 and 22% more than its last 4 quarters average of 3.2
MGTX's equity is up by 20% from the previous quarter and by 4.2% YoY
The revenue has soared by 108% YoY and by 71% QoQ
MGTX's price to sales (P/S) is 4.1% higher than its 5-year quarterly average of 28.5
Efficiency
How efficient is MeiraGTx Holdings business performance
MGTX's ROS has soared by 70% year-on-year and by 45% since the previous quarter
MeiraGTx Holdings's return on equity has increased by 35% YoY and by 6% QoQ
MGTX's return on assets is up by 34% year-on-year and by 8% since the previous quarter
The ROIC rose by 33% YoY and by 3% QoQ
Dividends
What is MGTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MGTX.
Financial health
How did MeiraGTx Holdings financials performed over time
MeiraGTx Holdings's total assets is 47% higher than its total liabilities
The quick ratio has soared by 58% YoY
The company's current ratio rose by 44% YoY
MeiraGTx Holdings's debt is 9% lower than its equity
MGTX's equity is up by 20% from the previous quarter and by 4.2% YoY
The company's debt to equity fell by 17% QoQ and by 7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.